Burgos-Blasco, Barbara http://orcid.org/0000-0003-2178-6164
García-Feijóo, Julian
Gines-Gallego, Cristina
Perucho-Gonzalez, Lucía
Fernandez-Vigo, Jose Ignacio
Martinez de la Casa, Jose María
Saenz-Frances, Federico
Morales-Fernandez, Laura
Mendez-Hernandez, Carmen Dora
Article History
Received: 4 July 2022
Revised: 7 December 2022
Accepted: 12 December 2022
First Online: 20 December 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Hospital Clinico San Carlos, with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards and approved by the Hospital Clinico San Carlos Committee.
: Informed consent was obtained from all individual participants included in the study.
: B Burgos-Blasco, C Gines-Gallego, L Perucho-Gonzalez, Federico Saenz-Frances, L Morales-Fernandez, and CD Mendez-Hernandez have participated as coinvestigators in studies regarding the PreserFlo implant promoted by Santen.J Garcia-Feijoo has received research funding from Santen, Allergan, Glaukos, Alcon, AJL, Thea, Sight Science, Heidelberg, J&J, B&L, Pfizer, Zeiss, Ivantis, and iStar and is Advisory Board of Santen, Alcon, Allergan, Alimera, Thea, Glaukos, and iStar.JM Martinez de la Casa has received research funding from Santen, Ivantis, Allergan, Pfizer, Glaukos, and Thea; is advisory boards of Allergan, Santen, Alcon, Pfizer, Novartis, Thea, B&L, Glaukos, AJL, and Visufarma; and is a Speaker for Allergan, Santen, Alcon, Pfizer, Novartis, Thea, B&L, Glaukos, and ICare.